Danazol: An Effective Option in Acquired Amegakaryocytic Thrombocytopaenic Purpura

Acquired amegakaryocytic thrombocytopaenic purpura (AATP) is a rare haematological condition characterised by isolated thrombocytopaenia with normal other cell lines. It is often initially misdiagnosed as immune thrombocytopaenic purpura but has characteristic bone marrow findings of reduced megakar...

Full description

Saved in:
Bibliographic Details
Published in:Case reports in hematology 2015-01, Vol.2015 (2015), p.1-4
Main Authors: Mulroy, E., Chiruka, S., Gleeson, S.
Format: Article
Language:English
Subjects:
Blood platelets
Bone marrow
Case Report
Drug dosages
Hematology
Hepatitis
Pathogenesis
Success
Transplants & implants
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Acquired amegakaryocytic thrombocytopaenic purpura (AATP) is a rare haematological condition characterised by isolated thrombocytopaenia with normal other cell lines. It is often initially misdiagnosed as immune thrombocytopaenic purpura but has characteristic bone marrow findings of reduced megakaryocyte numbers. The optimal treatment of AATP is not clearly defined but revolves around immunosuppressive therapies. We report a case of successful treatment of AATP with danazol, an antioestrogenic medication. We also review the aetiologies and pathogenesis of the disorder and suggest that danazol should be considered as an effective alternative to potent immunosuppression in AATP.
ISSN:2090-6560
2090-6579
DOI:10.1155/2015/171253